# clm_E1F6AE4E3122

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_research_and_development  
value: 1,192,000,000 United States dollar  
valid_from: 2018-06-30  
valid_to: 2018-09-30  
published: 2018-08-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_914CFB3695E1  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly research and development: 1,192,000,000 United States dollar", as of 2018-06-30 (until 2018-09-30). Claim clm_E1F6AE4E3122, https://asof.is/claim/clm_E1F6AE4E3122, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000022/0000882095-18-000022-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2018, filed 2018-08-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209518000022/0000882095-18-000022-index.htm (primary, SEC EDGAR 10-Q Q2 FY2018, published 2018-08-06)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_research_and_development | 937,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_E1F6AE4E3122](/claim/clm_E1F6AE4E3122.md) | [clm_BADB05CE1396](/claim/clm_BADB05CE1396.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.